ArticleBriefings in bioinformatics2026
A progressive fine-tuning framework with dynamic parameter selection for low-resource peptide-GPCR interaction prediction.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
G protein-coupled receptors (GPCRs) are among the most important drug targets, and peptide therapeutics are rapidly emerging. However, accurate prediction of peptide-GPCR interactions (PepGI) remains challenging due to the scarcity of high-quality data and the poor generalization of existing drug-target interaction (DTI) models, which are largely trained on small molecule data. Here, we introduce a progressive fine-tuning framework with a dynamic parameter selection strategy that adaptively selects critical fine-tuning parameters using Fisher information. Our method begins with pretraining on a large small molecule-GPCR dataset, followed by intermediate fine-tuning on peptide-target data to alleviate the representation mismatch across heterogeneous ligand modalities. Finally, the task-specific fine-tuning is performed on the low-resource PepGI scenario. Extensive experiments show that our approach significantly outperforms baselines across multiple evaluation metrics, and exhibits robust generalization under few-shot and practical cold-start settings. Overall, this work offers an effective solution for low-resource peptide-GPCR prediction and presents a transferable framework for cross-structure DTI modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.